Granules India

Granules India outlines the inspection outcome and operational role of its U.S. subsidiary

The Centres were inaugurated at the Institute’s Technology Research Park

Granules India, in partnership with the National Institute of Pharmaceutical Education and Research (NIPER), S.A.S Nagar,…

The first panel discussion at FDD Conclave 2025 was on ‘Accelerating OSD innovation: From R&D to Market’. It set the tone for…

This places the company in the 97th percentile, among the top 5 per cent of all companies assessed globally across all industries…

The ₹192.5 crore transaction marks Granules India's entry into the CDMO segment and expands its presence in peptide-based APIs

As part of its CSR efforts, Granules India’s Breast Health Express screened 100 women officers and expanded outreach on early…

Acquisition strengthens Granules’ entry into the peptide-based therapeutics market and enhances CDMO capabilities through Senn’s…

Industry players urge the government to prioritise funding for research into botanical herbs and address the challenge of API…

New approval supports treatment for ADHD and binge eating disorder while addressing critical drug shortages